India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 million....

Rich countries have hundreds of millions of vaccine doses that could help combat an mpox outbreak in Africa, where donated shots are insuff...

Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to extend gains from l...

“At the moment, the world is relying on one manufacturer, Bavarian Nordic, for the monkeypox vaccine,” said Manish Bhargava, a fund manager...

The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remde...

French officials believe that France needs to act rapidly to close the gap and not surrender more ground to emerging powers, notably China.

Following a review of the FDA decision, the South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had dec...

Johnson & Johnson, with help from the Biden administration, is taking over a Baltimore vaccine production facility that was the site of a m...

J&J locked arms with Emergent in April 2020, enlisting the lesser-known company to manufacture its vaccine. At the time, Emergent's Bayview...

A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing...

The European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the do...

Scientists and drug companies across the world are accelerating various treatments and vaccine options to tackle Covid-19, which has claime...

UPL signed a definitive agreement to acquire Arysta Life Science for $4.2 billion in an all cash consideration last Friday.

The first-aid dressing done with help of Axiostat stops uncontrollable bleeding within just 2-3 minutes of its application, thus saving liv...

The round also gave an exit with 7X returns to the company’s first institutional investor, GVFL, an Ahmedabad-based venture capital firm.

Funded by Accel Partners, IDG Ventures and GVFL, the production unit in Ahmedabad will have installed capacity of 2.5 lakh units per year w...

The new antibodies identify and neutralise Marburg virus which has a mortality rate of up to 90 per cent.